| 摘要: |
| 阿尔茨海默症(Alzheimer’s disease,AD)为进行性的神经退行性疾病,目前缺乏有效的治疗手段。β淀粉样蛋白(β-amyloid,Aβ)在脑神经细胞外过度沉积形成的寡聚体和淀粉样斑块与AD的发生、发展密切相关。γ-分泌酶是Aβ代谢过程中的关键酶,为研发AD治疗药物的关键靶点。针对此靶点研发的γ-分泌酶调节剂(γ-Secretase Modulators,GSM)因对Notch等蛋白影响较小,有广阔的应用前景。本文总结了源于黑升麻(Black cohosh,Cimicifuga racemosa)的环阿尔廷型三萜为先导物的结构优化历程,最终获得GSM药物候选物SPI-1865,以期为GSM的开发与改造提供有价值的参考。 |
| 关键词: 阿尔茨海默症 β淀粉样蛋白 γ-分泌酶 γ-分泌酶调节剂 SPI-1865 |
| DOI:10.13506/j.cnki.jpr.2017.04.001 |
| 基金项目:国家自然科学基金项目(No.81561148011、No.81473110、No.81273397) |
|
|
|
| An overview in research and development process of a novel γ-secretase modulator SPI-1865 |
| LYU Xue,HU Lihong |
| (State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,University of Chinese Academy of Sciences,Shanghai 201203,China) |
| Abstract: |
| Alzheimer’s disease is a progressive neurodegenerative disorder,which is lack of efficient treatment measures.The β-amyloid (Aβ) oligomers and senile plaques,which are the result of β-amyloid aggregation outside the brain neurons,are strongly implicated the pathogenesis of AD.γ-Secretase,a key enzyme involved in generation of Aβ,is a potential target in the development of drugs for AD therapy.γ-Secretase modulators are highly selective and have broad application prospects.This article briefly reviewed the development process of a novel γ-Secretase modulator SPI-1865,aiming at providing valuable information for development and structural modifications of related GSM. |
| Key words: Alzheimer’s disease β-amyloid γ-Secretase γ-Secretase modulators SPI-1865 |